Ashwin joined Royalty Pharma in 2023. Ashwin has nearly two decades of experience advising biopharmaceutical companies on mergers and acquisitions as well as capital formation. Prior to joining Royalty Pharma, Ashwin was a managing director of Morgan Stanley and led the firm’s West Coast Biotechnology Investment Banking practice. Ashwin received both his MD in the accelerated Honors Program in Medical Education and his BA in economics with highest distinction from Northwestern University.
